A Comparison of Clinical and Radiographic Signs of Nontuberculous Mycobacterial Pulmonary Disease, Destructive Drug-Resistant Pulmonary Tuberculosis and a Combination of Nontuberculous Mycobacterium Pulmonary Disease and Pulmonary Tuberculosis

A misdiagnosis of isolated pulmonary tuberculosis (pTB) is highly likely when a patient has nontuberculous mycobacterial pulmonary disease (NTMPD) or a combination of nontuberculous mycobacterium pulmonary disease and pulmonary tuberculosis. Frequently, bacterial excretion is absent or only Mycobacteria tuberculosis (MBT) is found. This often results in an incorrect diagnosis and subsequent misinformed treatment regimes. In order to determine possible clinical and radiographic differences between patients with NTMPD (Group 1), destructive drug-resistant pulmonary tuberculosis (Group 3) and a combination of NTMPD and pTB (Group 2) we compare clinical and radiographic signs for these three patient groups. When comparing with Group 3 (2.5%), Groups 1 (25%) and 2 (17.4%) have a substantially higher incidence of pulmonary haemorrhages. Thus, upon clinically observing the combination of pTB and NTMPD, there are no pathognomonic clinical and radiographic detected symptoms. However, the presence of an indolent course, hemoptysis and bronchiectasis in the presence of acid-fast bacteria (or identified MBT) in the sputum makes it possible to suspect not simple pTB, but a combination of pTB and NTMPD. To clarify this necessitated in-depth bacteriological examination.

[1]  A. Meenakshisundaram,et al.  Clinical profile of patients hospitalized with hemoptysis , 2022, Journal of family medicine and primary care.

[2]  D. Giller,et al.  Surgical Treatment of Nontuberculous Mycobacterial Pulmonary Disease, and a Combination of Nontuberculous Mycobacterium Pulmonary Disease and Pulmonary Tuberculosis. , 2022, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[3]  O'Neil Green,et al.  Nontuberculous Mycobacterial Pulmonary Disease: A Clinical and Radiologic Update. , 2021, Seminars in roentgenology.

[4]  S. Tahseen,et al.  Isolation of non-tuberculous mycobacteria among tuberculosis patients, a study from a tertiary care hospital in Lahore, Pakistan , 2021, BMC Infectious Diseases.

[5]  Eui Jin Hwang,et al.  Clinical Implications of Size of Cavities in Patients With Nontuberculous Mycobacterial Pulmonary Disease: A Single-Center Cohort Study , 2020, Open forum infectious diseases.

[6]  M. Fortin,et al.  Aetiology, diagnosis and treatment of moderate-to-severe haemoptysis in a North American academic centre , 2020, ERJ Open Research.

[7]  A. Ishimatsu,et al.  Association of serum antibodies against the Mycobacterium avium complex and hemoptysis: a cross-sectional study , 2020, BMC Infectious Diseases.

[8]  A. Kipnis,et al.  Non-tuberculous mycobacterial lung disease: a brief review focusing on radiological findings , 2020, Revista da Sociedade Brasileira de Medicina Tropical.

[9]  Илья Владимирович Петров,et al.  Микробиологические и эпидемиологические особенности микобактериозов , 2020 .

[10]  J. Brożek,et al.  Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline , 2020, European Respiratory Journal.

[11]  M. Makarova,et al.  No ntuberculous Mycobacteria , 2020 .

[12]  A. Vágvölgyi,et al.  [Indications and perioperative results of completion pneumonectomy]. , 2019 .

[13]  L. Chernousova,et al.  [Non - tuberculous mycobacteriosis of the lungs - diagnostic possibilities in the practice of the pulmonologist]. , 2019, Terapevticheskii arkhiv.

[14]  Min Uk Kim,et al.  Hemoptysis requiring bronchial artery embolization in patients with nontuberculous mycobacterial lung disease , 2019, BMC Pulmonary Medicine.

[15]  M. Loebinger,et al.  Nontuberculous Mycobacterial Pulmonary Disease , 2015 .

[16]  S. Beal,et al.  Evaluating differences in tuberculosis and nontuberculous mycobacterial lung disease in Florida. , 2019, American journal of infection control.

[17]  П. И. Елисеев,et al.  ДИАГНОСТИКА И ЛЕЧЕНИЕ ЛЕГОЧНОГО МИКОБАКТЕРИОЗА У ПАЦИЕНТОВ С ПОДОЗРЕНИЕМ НА ТУБЕРКУЛЕЗ ЛЕГКИХ , 2018 .

[18]  C. Haworth,et al.  Introducing the new BTS Guideline: Management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) , 2017, Thorax.

[19]  C. Haworth,et al.  British Thoracic Society Guideline for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) , 2017, BMJ Open Respiratory Research.

[20]  A. Bhalla,et al.  Etiology and outcome of moderate-to-massive hemoptysis: Experience from a tertiary care center of North India , 2017, International journal of mycobacteriology.

[21]  Елена Евгеньевна Ларионова,et al.  МОНИТОРИНГ ВИДОВОГО РАЗНООБРАЗИЯ НЕТУБЕРКУЛЕЗНЫХ МИКОБАКТЕРИЙ В РЯДЕ ОБЛАСТЕЙ РФ С ИСПОЛЬЗОВАНИЕМ ДНК-СТРИПОВ GENOTYPE MYCOBACTERIUM CM/AS (HAIN LIFESCIENCE, ГЕРМАНИЯ) , 2017 .

[22]  Mi Young Kim,et al.  Comparison of chest CT findings in nontuberculous mycobacterial diseases vs. Mycobacterium tuberculosis lung disease in HIV-negative patients with cavities , 2017, PloS one.

[23]  Charles L Daley,et al.  Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease: Clinicians' Perspectives , 2016, Tuberculosis and respiratory diseases.

[24]  J. Yim,et al.  Non-tuberculous mycobacterial lung disease: diagnosis based on computed tomography of the chest , 2016, European Radiology.

[25]  Qi Wu,et al.  Bronchial Artery Embolization for Hemoptysis: A Retrospective Observational Study of 344 Patients , 2015, Chinese medical journal.

[26]  Z. Hong,et al.  Surgical treatment efficacy in 172 cases of tuberculosis-destroyed lungs. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[27]  C. Daley,et al.  Pulmonary non-tuberculous mycobacterial infections. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[28]  Robert Horsburgh,et al.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. , 2007, American journal of respiratory and critical care medicine.

[29]  Kyung Soo Lee,et al.  Drug-sensitive tuberculosis, multidrug-resistant tuberculosis, and nontuberculous mycobacterial pulmonary disease in nonAIDS adults: comparisons of thin-section CT findings , 2006, European Radiology.

[30]  O. Ashraf Hemoptysis, a developing world perspective , 2006, BMC pulmonary medicine.

[31]  M. Chung,et al.  Thin-Section CT Findings of Nontuberculous Mycobacterial Pulmonary Diseases: Comparison Between Mycobacterium avium-intracellulare Complex and Mycobacterium abscessus Infection , 2005, Journal of Korean medical science.

[32]  K. Lee,et al.  Bilateral bronchiectasis and bronchiolitis at thin-section CT: diagnostic implications in nontuberculous mycobacterial pulmonary infection. , 2005, Radiology.

[33]  M. Chung,et al.  Hypothesis on the evolution of cavitary lesions in nontuberculous mycobacterial pulmonary infection: thin-section CT and histopathologic correlation. , 2005, AJR. American journal of roentgenology.

[34]  J. Freixinet Surgical Indications for Treatment of Pulmonary Tuberculosis , 1997, World Journal of Surgery.

[35]  I. D. Johnston,et al.  Pulmonary Mycobacterium kansasii infection: comparison of radiological appearances with pulmonary tuberculosis. , 1996, Thorax.

[36]  R. C. Murry,et al.  Radiographic manifestations of pulmonary Mycobacterium kansasii infections. , 1978, AJR. American journal of roentgenology.

[37]  E. Shmakova,et al.  DETECTION OF NON-TUBERCULOSIS MYCOBACTERIA AMONG PATIENTS WITH PULMONARY TUBERCULOSIS LIVING IN TERRITORIES WITH DIFFERENT ENVIRONMENTAL BURDEN , 2021, Современные проблемы науки и образования (Modern Problems of Science and Education).

[38]  Mycobacteriosis of the lungs: difficulties of diagnosis and treatment (literature review) , 2020, Медицинский Альянс.

[39]  A. V. Tatarintsev,et al.  [Influence of surgical sanation of patients with destructive tuberculosis on the prevalence of tuberculosis and mortality]. , 2020, Khirurgiia.

[40]  A. Dixon,et al.  Nontuberculous Mycobacterial Disease , 2019, Respiratory Medicine.